TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33980290

Group type: EXPERIMENTAL
Intervention: Gratitude journal intervention (logging 5 things they felt grateful for daily for 2 weeks)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (daily self-evaluations only)
Number of subjects: 84
Study: 36008918

Group type: EXPERIMENTAL
Intervention: ProSAAF intervention
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 348
Study: 33909357

Group type: EXPERIMENTAL
Intervention: Tiaodu Jieyu acupuncture combined with sertraline hydrochloride (50 mg once daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sertraline hydrochloride (50 mg once daily)
Number of subjects: 120
Study: 35228753

Group type: EXPERIMENTAL
Intervention: 100 mg of canagliflozin
Number of subjects: 476

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 476
Study: 32649961

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo saline
Number of subjects: 30
Study: 35302909

Group type: EXPERIMENTAL
Intervention: CDS
Number of subjects: 5054

Group type: EXPERIMENTAL
Intervention: CDS+SDMT
Number of subjects: 5054

Group type: COMPARATOR
Intervention: UC
Number of subjects: 5054
Study: 35453106

Group type: EXPERIMENTAL
Intervention: Dynamic stabilization
Number of subjects: 293

Group type: COMPARATOR
Intervention: Fusion
Number of subjects: 293
Study: 34067292

Group type: EXPERIMENTAL
Intervention: PA coaching intervention designed to increase objectively measured moderate‐to‐vigorous‐intensity PA (MVPA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 33411687

Group type: EXPERIMENTAL
Intervention: ticagrelor/aspirin
Number of subjects: 365

Group type: COMPARATOR
Intervention: clopidogrel/aspirin
Number of subjects: 365
Study: 34605897

Group type: EXPERIMENTAL
Intervention: Febuxostat treatment
Number of subjects: 1070
Study: 34869490

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioral therapy (ICBT) for tinnitus
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 158
Study: 34730821

Group type: EXPERIMENTAL
Intervention: Reducing Stigma Among Healthcare Providers (RESHAPE) group
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (mhGAP-IG training)
Number of subjects: 88
Study: 33043881

Group type: EXPERIMENTAL
Intervention: Stratified care (advice and up to two sessions of physiotherapy)
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Stratified care (up to six sessions of physiotherapy)
Number of subjects: 476

Group type: EXPERIMENTAL
Intervention: Stratified care (fast-tracked to MRI and spinal specialist opinion)
Number of subjects: 476

Group type: COMPARATOR
Intervention: Usual care (stepped-care approach without stratification)
Number of subjects: 476
Study: 35363598

Group type: EXPERIMENTAL
Intervention: BWHIIT (n = 20)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CON (n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BWHIIT
Number of subjects: 30

Group type: COMPARATOR
Intervention: CON
Number of subjects: 30
Study: 34030999

Group type: EXPERIMENTAL
Intervention: Opaque eye coverage during surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: No eye coverage during surgery
Number of subjects: 60
Study: 33332396

Group type: EXPERIMENTAL
Intervention: Fitness Qigong
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control
Number of subjects: 103
Study: 34836822

Group type: EXPERIMENTAL
Intervention: Educational intervention (educational day, clinical supervision, reminders)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 258
Study: 34109630

Group type: EXPERIMENTAL
Intervention: Trilaciclib
Number of subjects: 242

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study: 32527346

Group type: EXPERIMENTAL
Intervention: Xuebijing 100 mL group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Xuebijing 50 mL group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment group
Number of subjects: 60
Study: 35312778

Group type: EXPERIMENTAL
Intervention: Identity-based group (treatment group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Individual-level (control group)
Number of subjects: 25
Study: 34579741

Group type: EXPERIMENTAL
Intervention: Anisodamine (0.1-0.5 mg/kg/hour)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 355
Study: 35250582

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with honeysuckle before rash occurred (Arm A)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Symptomatic treatment with honeysuckle when rash occurred (Arm B)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Conventional treatment with minocycline and a topical solution when rash occurred (Arm C)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with honeysuckle (Arm A)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Honeysuckle treatment (Arm A, B)
Number of subjects: 139
Study: 34292474

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure target of 110–139 mm Hg
Number of subjects: 171

Group type: COMPARATOR
Intervention: Standard treatment blood pressure target of 140–179 mm Hg
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Patients with diffusion-weighted imaging hyperintense lesions
Number of subjects: 171
Study: 33896847

Group type: EXPERIMENTAL
Intervention: Bilateral stimulation of the subthalamus nuclei (STN‐DBS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Unilateral or bilateral STN‐DBS
Number of subjects: 18

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 18
Study: 33358203

Group type: EXPERIMENTAL
Intervention: Social robot intervention (PARO)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual care condition
Number of subjects: 41
Study: 32896359

Group type: EXPERIMENTAL
Intervention: Supra segmental training (CWHIt)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No training (CWHI)
Number of subjects: 30
Study: 34232456

Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise for 12 weeks
Number of subjects: 105

Group type: COMPARATOR
Intervention: Health education for 12 weeks (Control)
Number of subjects: 105
Study: 32149480

Group type: EXPERIMENTAL
Intervention: Bilateral anodal transcranial direct current stimulation (tDCS) applied over the left and right prefrontal and motor areas, 10 sessions (20‐min durations, five per week)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham tDCS stimulation
Number of subjects: 50
Study: 35072694

Group type: EXPERIMENTAL
Intervention: Mindfulness Intervention for New Interns (7 hour-long sessions of a monthly mindfulness curriculum)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Active control (monthly 1-hour social lunches)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Mindfulness Intervention for New Interns
Number of subjects: 340

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 340
Study: 33952195

Group type: EXPERIMENTAL
Intervention: Experimental treatment in a single-arm design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-arm design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed designs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group-sequential two-arm trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fixed single-arm design
Number of subjects: 0
Study: 32840074

Group type: EXPERIMENTAL
Intervention: Background music (rock music)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Background music (classical music)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Background music (any type)
Number of subjects: 15

Group type: COMPARATOR
Intervention: No music
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Rock music
Number of subjects: 15
Study: 33780481

Group type: EXPERIMENTAL
Intervention: Ivermectin, diethylcarbamazine, and albendazole (IDA)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Diethylcarbamazine plus albendazole (DA)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 55
Study: 32503661

Group type: EXPERIMENTAL
Intervention: EHR-facilitated cancer symptom control (E2C2) intervention, which includes two levels of care: Level 1 - low-touch automated self-management support; Level 2 - nurse-managed collaborative care for severe symptoms.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EHR-facilitated cancer symptom control (E2C2) intervention
Number of subjects: 0
Study: 32019539

Group type: EXPERIMENTAL
Intervention: RFR + PFP
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: RFR only
Number of subjects: 542

Group type: COMPARATOR
Intervention: PFP only
Number of subjects: 542
Study: 34676618

Group type: EXPERIMENTAL
Intervention: Nurse-guided incentive spirometry for 48 hours postextubation
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 89
Study: 35300729

Group type: EXPERIMENTAL
Intervention: MAINTAIN instrument with a score of 18 or higher
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: MAINTAIN instrument with a score of 22 or higher
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: MAINTAIN instrument with a score of 20
Number of subjects: 249
Study: 32753874

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 11
Study: 36198061

Group type: EXPERIMENTAL
Intervention: Sublingual dexmedetomidine 180 μg
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Sublingual dexmedetomidine 120 μg
Number of subjects: 380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380
Study: 36029330

Group type: EXPERIMENTAL
Intervention: RIRS (Group A)
Number of subjects: 186

Group type: COMPARATOR
Intervention: MiniPerc (Group B)
Number of subjects: 186
Study: 36481692

Group type: COMPARATOR
Intervention: 3D‐conformal radiotherapy (3D‐RT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: VMAT planning
Number of subjects: 34

Group type: COMPARATOR
Intervention: 3D‐RT
Number of subjects: 34
Study: 33743583

Group type: EXPERIMENTAL
Intervention: IV-based estimation of Cox's model for time-dependent hazard ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IV-based estimation of Cox's model for log-linear hazard ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Comparison to partial likelihood estimator and two other IV-based approaches
Number of subjects: 0
Study: 36273769

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 251
Study: 34636355

Group type: EXPERIMENTAL
Intervention: Gellhorn pessary
Number of subjects: 181

Group type: COMPARATOR
Intervention: Ring pessary
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Predictive model
Number of subjects: 181
Study: 34370925

Group type: EXPERIMENTAL
Intervention: Occupational therapy interventions for daily activities and quality of life
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33109252

Group type: EXPERIMENTAL
Intervention: Kabasura Kudineer (KSK) - 60ml decoction orally in the morning and evening for 14 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vitamin C (60000 IU) and Zinc (100mg) - orally in the morning and evening for 14 days
Number of subjects: 60
Study: 34431493

Group type: EXPERIMENTAL
Intervention: LLF580 300 mg subcutaneously every 4 weeks for 3 doses
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 34278392

Group type: EXPERIMENTAL
Intervention: Indoor microorganisms (bacterial genera from Actinobacteria, Alphaproteobacteria, and Cyanobacteria)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Indoor microorganisms (four fungal genera from Ascomycota: Devriesia, Endocarpon, Sarcinomyces, and an unclassified genus from Herpotrichillaceae)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: House dust mite (HDM) allergens and outdoor NO2 concentration
Number of subjects: 308
Study: 32584117

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive-behavioral therapy (CBT)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Waitlist (before treatment)
Number of subjects: 101
Study: 34980572

Group type: EXPERIMENTAL
Intervention: Picture group (P) - shown preoperative photograph for 5 min at each postoperative visit
Number of subjects: 29

Group type: COMPARATOR
Intervention: No picture group (NP) - not shown preoperative photograph
Number of subjects: 29
Study: 34376233

Group type: EXPERIMENTAL
Intervention: Default strategy within the mechanical ventilation order
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Accountable justification strategy within the mechanical ventilation order
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of default strategy and accountable justification strategy within flowsheet documentation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Flowsheet documentation strategy (adopted by all ICUs 6 months after initial strategies)
Number of subjects: 12
Study: 33185167

Group type: EXPERIMENTAL
Intervention: Intra-articular injections of Platelet Rich Plasma (PRP), 3 injections at monthly intervals.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Single intra-articular injection of steroid.
Number of subjects: 60
Study: 33183362

Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Enriched Supportive Therapy (EST)
Number of subjects: 62
Study: 33199051

Group type: EXPERIMENTAL
Intervention: Mindful Awareness Practice (MAP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 55
Study: 32925045

Group type: EXPERIMENTAL
Intervention: Multidomain intervention (diet, exercise, cognitive training, vascular risk management)
Number of subjects: 60

Group type: COMPARATOR
Intervention: General health advice (control group)
Number of subjects: 60
Study: 37207014

Group type: EXPERIMENTAL
Intervention: SUPERA technique
Number of subjects: 36

Group type: COMPARATOR
Intervention: Hybrid technique
Number of subjects: 36
Study: 36376127

Group type: EXPERIMENTAL
Intervention: Virtual Reality
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Buzzy (Cold Vibration Device)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control Group (Distraction technique of talking and asking questions)
Number of subjects: 150
Study: 34002035

Group type: EXPERIMENTAL
Intervention: Genetically predicted BMI
Number of subjects: 898130

Group type: EXPERIMENTAL
Intervention: Genetically predicted WHR
Number of subjects: 898130
Study: 33302667

Group type: EXPERIMENTAL
Intervention: Diversified and staged health education
Number of subjects: 180

Group type: COMPARATOR
Intervention: Routine health education
Number of subjects: 180
Study: 34698501

Group type: EXPERIMENTAL
Intervention: GRAd-COV2 vaccine (single intramuscular administration at three escalating doses)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: GRAd-COV2 vaccine
Number of subjects: 90
Study: 34943312

Group type: EXPERIMENTAL
Intervention: Low-dose, high-frequency simulation training
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: At least monthly training
Number of subjects: 0
Study: 34933644

Group type: EXPERIMENTAL
Intervention: OJ with 6g β-glucan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OJ with 3g β-glucan
Number of subjects: 0

Group type: COMPARATOR
Intervention: OJ alone
Number of subjects: 0
Study: 32065984

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT), n = 17
Number of subjects: 38

Group type: COMPARATOR
Intervention: Psychoeducational group (OCD-EP), n = 21
Number of subjects: 38
Study: 34982820

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) therapy
Number of subjects: 13487

Group type: COMPARATOR
Intervention: Usual care (comparison group)
Number of subjects: 13487
Study: 33938952

Group type: EXPERIMENTAL
Intervention: Klar bleiben intervention (contract management, feedback system)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 92
Study: 34001823

Group type: EXPERIMENTAL
Intervention: Visual analysis of PET/CT
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Random forest classifier on training set
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Model on independent test set
Number of subjects: 30
Study: 32271833

Group type: EXPERIMENTAL
Intervention: READY for MS (resilience group training program based on Acceptance and Commitment Therapy)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Relaxation (active control intervention)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: READY for MS
Number of subjects: 39

Group type: COMPARATOR
Intervention: Relaxation + READY (after trial completion)
Number of subjects: 39
Study: 35342289

Group type: EXPERIMENTAL
Intervention: Aclidinium bromide/formoterol fumarate (AB/FF)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 32040398

Group type: EXPERIMENTAL
Intervention: New Nutrition Facts label (NFL)
Number of subjects: 1156

Group type: COMPARATOR
Intervention: Current Nutrition Facts label (NFL)
Number of subjects: 1156
Study: 34172640

Group type: EXPERIMENTAL
Intervention: On-line hemodiafiltration (OL-HDF)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Conventional hemodialysis (CHD)
Number of subjects: 47
Study: 34108229

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 1471

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1471
Study: 35312347

Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis
Number of subjects: 112

Group type: COMPARATOR
Intervention: Digital Mammography
Number of subjects: 112
Study: 32426812

Group type: EXPERIMENTAL
Intervention: Azithromycin distributions
Number of subjects: 0
Study: 36191329

Group type: EXPERIMENTAL
Intervention: Permitting suggestions: 'You are aware of your surroundings and any distractions that might disturb your dream.'
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Excluding suggestions: 'No outside stimulus will disturb your sleep.'
Number of subjects: 32
Study: 34142500

Group type: EXPERIMENTAL
Intervention: Robot assisted percutaneous reduction and cannulated screw fixation through tarsal sinus incision
Number of subjects: 44

Group type: COMPARATOR
Intervention: Open reduction and internal fixation via traditional tarsal sinus incision
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups (trial and control)
Number of subjects: 44
Study: 35311975

Group type: EXPERIMENTAL
Intervention: Resin infiltration (ICON, DMG, Hamburg, Germany)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP, Toothmousse, GC corporation, Germany)
Number of subjects: 60
Study: 34843141

Group type: EXPERIMENTAL
Intervention: Standardised milk-based formulation (SMBF)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Standardised non-milk based formulation (SNMBF)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Hospital-based formulation (HBF)
Number of subjects: 157
Study: 36321244

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid (ALA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of NAC + ALA
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sperm freezing medium (SFM)
Number of subjects: 30
Study: 33119057

Group type: EXPERIMENTAL
Intervention: Olfactory threshold and odor identification tests using 'Sniffin' Sticks' and 'U‐Sniff'
Number of subjects: 200
Study: 32763435

Group type: EXPERIMENTAL
Intervention: Ramp-up mode of the Dentapen electronic syringe
Number of subjects: 116

Group type: COMPARATOR
Intervention: Continuous mode of the Dentapen electronic syringe
Number of subjects: 116
Study: 35614169

Group type: EXPERIMENTAL
Intervention: Routine OUD screening implementation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Promising implementation strategies
Number of subjects: 10
Study: 36279833

Group type: EXPERIMENTAL
Intervention: MILO (Motivational Interviewing for Loved Ones) intervention
Number of subjects: 40
Study: 33694027

Group type: EXPERIMENTAL
Intervention: Hydrodynamic transalveolar approach (HTA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Lateral window technique (LW)
Number of subjects: 22
Study: 32160915

Group type: EXPERIMENTAL
Intervention: Metoprolol succinate
Number of subjects: 0
Study: 35099626

Group type: EXPERIMENTAL
Intervention: Mosquito mesh (MM)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional polypropylene mesh (CM)
Number of subjects: 62
Study: 33678179

Group type: EXPERIMENTAL
Intervention: PACE Steps to Success palliative care program
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 459
Study: 32238992

Group type: EXPERIMENTAL
Intervention: Comprehensive oral healthcare including oral health examinations, oral health education for children and their guardians, local fluoride application and dental treatment
Number of subjects: 398

Group type: COMPARATOR
Intervention: Oral health examinations twice a year
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Comprehensive oral healthcare measures
Number of subjects: 398
Study: 34806793

Group type: EXPERIMENTAL
Intervention: Glucose-lowering interventions (metformin, dapagliflozin, or exercise)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32496835

Group type: EXPERIMENTAL
Intervention: Person-centred care
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control conditions (not specified)
Number of subjects: 42
Study: 34473249

Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy (antiarrhythmic drugs and AF ablation)
Number of subjects: 2790

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 2790

Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy
Number of subjects: 2790
Study: 34469706

Group type: EXPERIMENTAL
Intervention: 10 days of intravenous antimicrobials
Number of subjects: 982

Group type: COMPARATOR
Intervention: 14 days of intravenous antimicrobials
Number of subjects: 982

Group type: COMPARATOR
Intervention: 21 days of intravenous antimicrobials
Number of subjects: 982
Study: 34404592

Group type: EXPERIMENTAL
Intervention: Maintaining serum potassium at ≥3.6 mEq/L
Number of subjects: 160

Group type: COMPARATOR
Intervention: Maintaining serum potassium at ≥4.5 mEq/L
Number of subjects: 160